A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
Clinical trial NCT07541534 · RECRUITING
Trial details
- NCT number
- NCT07541534
- Sponsor
- Shanghai Henlius Biotech
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2027-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.